Historical salary details - Mr. George J. Morrow, Independent Director, Align Technology, Inc.
Mr. George J. Morrow is the Independent Director of Align Technology, Inc.. They also hold 1 other positions in and Neurocrine Biosciences, Inc..
Mr. George J. Morrow
Independent Director
-
Gross Remuneration
-
Current Company
Align Technology, Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Align Technology, Inc. | Independent Director | - | - |
| 2024 | Neurocrine Biosciences, Inc. | Independent Director | - | - |
| 2023 | Neurocrine Biosciences, Inc. | Independent Director | 479.5 K | 0.0 % |
| 2023 | Align Technology, Inc. | Independent Director | 381.8 K | 0.0 % |
| 2022 | Neurocrine Biosciences, Inc. | Independent Director | 479.5 K | 0.0 % |
| 2022 | Align Technology, Inc. | Independent Director | 381.8 K | 0.1 % |
| 2021 | Neurocrine Biosciences, Inc. | Independent Director | 479.5 K | 0.8 % |
| 2021 | Align Technology, Inc. | Independent Director | 381.5 K | -0.1 % |
| 2020 | Neurocrine Biosciences, Inc. | Independent Director | 475.8 K | -10.0 % |
| 2020 | Align Technology, Inc. | Independent Director | 382.0 K | 0.0 % |
| 2019 | Neurocrine Biosciences, Inc. | Independent Director | 528.6 K | -27.6 % |
| 2019 | Align Technology, Inc. | Independent Director | 382.0 K | -0.0 % |
| 2019 | Fresh Tracks Therapeutics Inc | Independent Director | - | - |
| 2018 | Neurocrine Biosciences, Inc. | Independent Director | 730.3 K | 44.6 % |
| 2018 | Align Technology, Inc. | Independent Director | 382.1 K | -24.2 % |
| 2018 | Fresh Tracks Therapeutics Inc | Independent Director | - | - |
| 2017 | Neurocrine Biosciences, Inc. | Independent Director | 505.0 K | 8.1 % |
| 2017 | Align Technology, Inc. | Independent Director | 503.8 K | 10.2 % |
| 2017 | Fresh Tracks Therapeutics Inc | Independent Director | 73.3 K | -4.9 % |
| 2016 | Neurocrine Biosciences, Inc. | Independent Director | 467.2 K | -56.4 % |
| 2016 | Align Technology, Inc. | Independent Director | 457.2 K | 14.3 % |
| 2016 | Fresh Tracks Therapeutics Inc | Independent Director | 77.1 K | -18.3 % |
| 2015 | Neurocrine Biosciences, Inc. | Independent Director | 1.1 M | - |
| 2015 | Align Technology, Inc. | Independent Director | 400.1 K | 14.4 % |
| 2015 | Fresh Tracks Therapeutics Inc | Independent Director | 94.3 K | -8.7 % |
| 2014 | Align Technology, Inc. | Independent Director | 349.8 K | -2.2 % |
| 2014 | Fresh Tracks Therapeutics Inc | Independent Director | 103.3 K | -28.1 % |
| 2013 | Align Technology, Inc. | Independent Director | 357.7 K | 14.9 % |
| 2013 | Fresh Tracks Therapeutics Inc | Independent Director | 143.8 K | 29.3 % |
| 2012 | Align Technology, Inc. | Independent Director | 311.5 K | 19.3 % |
| 2012 | Fresh Tracks Therapeutics Inc | Independent Director | 111.2 K | - |
| 2011 | Align Technology, Inc. | Independent Director | 261.2 K | 28.9 % |
| 2010 | Align Technology, Inc. | Director | 202.7 K | 20.6 % |
| 2009 | Align Technology, Inc. | Director | 168.1 K | -39.1 % |
| 2008 | Align Technology, Inc. | Director | 276.2 K | 8.1 % |
| 2007 | Align Technology, Inc. | Director | 255.5 K | 103.7 % |
| 2006 | Align Technology, Inc. | Director | 125.4 K | - |
| 2005 | Align Technology, Inc. | Director | - | - |